S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:CHYR

(CHYR) (CHYR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
62,347 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CHYR stock logo

About (CHYR) Stock (NASDAQ:CHYR)

ChyronHego Corporation is a United States-based company, which is engaged in broadcast graphics creation, playout, and real-time data visualization. The Company offers a range of products and services for live television, news, sports, corporate and government video production. It offers products, such as broadcast graphics, including Lyric Family, Axis World Graphics and Mosaic; production and automation, including Live Arena, Live Compositor and Live Assist; channel branding and tickers, including Channel Box PRIME, Channel Box and NewsTicker Family; weather graphics, including Metacast; studio and virtual solutions, including Virtual Football, Virtual Placement and Hybrid Virtual Studios, and sports tracking and analysis, including Sports Technology and Coach Paint. Its end-to-end graphics offerings include hosted services for graphics creation and order management, channel branding, weather graphics, graphics asset management, touch graphics, virtual placement and player tracking.

CHYR Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
I Beam Market is booming in near Future 2023-2028
See More Headlines
Receive CHYR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CHYR) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2014
Today
4/19/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:CHYR
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

CHYR Stock Analysis - Frequently Asked Questions

How were (CHYR)'s earnings last quarter?

(CHYR) (NASDAQ:CHYR) issued its quarterly earnings data on Monday, November, 10th. The company reported $0.03 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.03. The business had revenue of $16.01 million for the quarter, compared to analysts' expectations of $15.70 million.

What other stocks do shareholders of (CHYR) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (CHYR) investors own include General Motors (GM), Curis (CRIS), Ford Motor (F), Albireo Pharma (ALBO), Agenus (AGEN), Aeterna Zentaris (AEZS), Authentidate (ADAT), Acasti Pharma (ACST), Axcelis Technologies (ACLS) and Achillion Pharmaceuticals (ACHN).

This page (NASDAQ:CHYR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners